2023年6月最新SCI影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CLINICAL PHARMACOLOGY & THERAPEUTICS CLIN PHARMACOL THER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.8
54人评分
我要评分
声誉 8.8 影响力 7.1 速度 7.1 | |||||||||||||||||||||
| 期刊ISSN | 0009-9236 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| E-ISSN | 1532-6535 | |||||||||||||||||||||
| 2022-2023最新影响因子 （数据来源于搜索引擎） | 6.7 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2023年6月16日：6.03 | |||||||||||||||||||||
| 2022-2023自引率 | 7.50%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 6.6 | |||||||||||||||||||||
| h-index | 173 | |||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||
| 期刊简介 | Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology. | |||||||||||||||||||||
| 期刊官方网站 | http://www.nature.com/clpt/index.html | |||||||||||||||||||||
| 期刊投稿网址 | http://cpt.msubmit.net/cgi-bin/main.plex | |||||||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CLINICAL PHARMACOLOGY & THERAPEUTICS的语言要求，还能让CLINICAL PHARMACOLOGY & THERAPEUTICS编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CLINICAL PHARMACOLOGY & THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | NATURE PUBLISHING GROUP, 75 VARICK ST, 9TH FLR, NEW YORK, USA, NY, 10013-1917 | |||||||||||||||||||||
| 出版商 | Wiley-Blackwell | |||||||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 1960 | |||||||||||||||||||||
| 年文章数 | 204点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 36.05% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 76.96% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2022-2023年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-9236%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均2月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约25% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CLINICAL PHARMACOLOGY & THERAPEUTICS顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021 Author: Luo, Xingxian; Du, Xin; Li, Zhuangqi; Qian, Feng; Yang, Yue Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. 113, Issue 1, pp. 170-181. DOI: 10.1002/cpt.2755 PubMed DOI |
| 2. | Development of Therapeutic Proteins for a New Subcutaneous Route of Administration after the Establishment of Intravenous Dosages: A Systematic Review Author: Xu, Zhenhua; Leu, Jocelyn H. H.; Xu, Yan; Nnane, Ivo; Liva, Sophia G. G.; Wang-Lin, Shun Xin; Kudgus-Lokken, Rachel; Vermeulen, An; Ouellet, Daniele Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. 113, Issue 5, pp. 1011-1029. DOI: 10.1002/cpt.2823 PubMed DOI |
| 3. | Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric Patients Author: Guo, Guimu; You, Xiang; Wu, Wanhong; Chen, Jiarui; Ke, Meng; Lin, Rongfang; Huang, Pinfang; Lin, Cuihong Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cpt.2815 PubMed DOI |
| 4. | The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data Author: Liu, Qi; Mathur, Raina; Xu, Yuan; Torres, Aracelis Z.; Miksad, Rebecca A.; Liu, Chao; Smithson, Haixia; Wang, Yaning; Zhu, Hao; Booth, Brian; Huang, Shiew-Mei; Zhi, Jizu; Sridhara, Rajeshwari; Blumenthal, Gideon Michael; Larkins, Erin; Mishra-Kalyani, Pallavi S.; Rivera, Donna R.; Kluetz, Paul G.; Sharon, Elad Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. 113, Issue 5, pp. 1139-1149. DOI: 10.1002/cpt.2874 PubMed DOI |
| 5. | Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose Author: Wang, Jing; Liang, Hua; Wang, You; Zheng, Xueying; Chen, Fei; Shao, Jian; Geng, Zhaoxu; Zheng, Li; Yang, Wenying; Weng, Jianping; Xu, Tao; Zhou, Kaixin Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cpt.2877 PubMed DOI |
| 6. | Challenges and Opportunities With Oncology Drug Development in China. Author: Bajaj G1, Gupta M1, Wang HH2, Barrett JS3, Tan M2, Rupalla K2, Bertz R1, Sheng J1. Journal: Clin Pharmacol Ther. 2019 Feb;105(2):363-375. doi: 10.1002/cpt.1017. Epub 2018 Mar 8. PubMed DOI |
| 7. | The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label. Author: Wang YH1,2, Chen CB1,2,3,4,5,6,7, Tassaneeyakul W8, Saito Y9, Aihara M10, Choon SE11, Lee HY12,13, Chang MM14, Roa FD15, Wu CW16, Zhang J17, Nakkam N8, Konyoung P18, Okamoto-Uchida Y9, Cheung CM14, Huang JW17, Ji C17, Cheng B17, Hui RC1,2,3, Chu CY19, Chen YJ20, Wu CY21, Hsu CK22, Chiu TM23, Huang YH1,2,3, Lu CW1,2,3,4, Yang CY1,2,3, Lin YT1,2,3, Chi MH1,2,3, Ho HC1,2,3, Lin JY1,2,3, Yang CH1,2,3, Chang YC1,2,3, Su SC1,2,5, Wang CW1,2,5, Fan WL5, Hung SI24, Chung WH1,2,3,4,5,6,7; Asian Severe Cutaneous Adverse Reaction Consortium. Journal: Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9. PubMed DOI |
| 8. | S-Nitrosylation of Prostacyclin Synthase Instigates Nitrate Cross-Tolerance In Vivo. Author: Zhou SN1, Lu JX2, Wang XQ1, Shan MR1, Miao Z1, Pan GP2, Jian X2, Li P2, Ping S2, Pang XY1, Bai YP3, Liu C4, Wang SX1,2,4. Journal: Clin Pharmacol Ther. 2019 Jan;105(1):201-209. doi: 10.1002/cpt.1094. Epub 2018 Aug 1. PubMed DOI |
| 9. | Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy. Author: Beumer JH1,2,3, Chu E1,3, Allegra C4, Tanigawara Y5, Milano G6, Diasio R7,8, Kim TW9, Mathijssen RH10, Zhang L11, Arnold D12, Muneoka K13, Boku N14, Joerger M15. Journal: Clin Pharmacol Ther. 2019 Mar;105(3):598-613. doi: 10.1002/cpt.1124. Epub 2018 Sep 11. PubMed DOI |
| 10. | Clinical Factors and Rate of Cough During Angiotensin-Converting Enzyme Inhibitor Treatment. Author: Ren H1,2,3, Luo JQ4, Shu Y5, Zhou HH1,2,3, Zhang W1,2,3. Journal: Clin Pharmacol Ther. 2019 Mar;105(3):566. doi: 10.1002/cpt.1218. Epub 2018 Sep 18. PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共4条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
